Hvis De er kvinde, vil denne behandling øge risikoen for at udvikle ovariel hyperstimulerings syndrom (OHSS) (se afsnit 4).
If you are a woman, this treatment increases your risk of developing ovarian hyperstimulation syndrome (OHSS) (see Section 4).